Hinkle ER, Wiedner HJ, Black AJ, Giudice J. RNA processing in skeletal muscle biology and disease. Transcription. 2019;10(1):1-20

1. Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65(8), 1038-1048. 2. Sen, C. K., Khanna, S., & Roy, S. (2006). Tocotrienols: Vitamin E beyond tocopherols. Life Sciences, 78(18), 2088-2098. 3. Aggarwal, B. B., Sundaram, C., Prasad, S., & Kannappan, R. (2010). Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases. Biochemical Pharmacology, 80(11), 1613-1631. 4. Nesaretnam, K., & Meganathan, P. (2011). Tocotrienols: Inflammation and cancer. Annals of the New York Academy of Sciences, 1229(1), 18-22. 5. Das, S., & Das, D. K. (2007). Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets, 6(3), 168-173. 6. Magosso, E., Ansari, M. A., Gopalan, Y., Shuaib, I. L., Wong, J. W., Khan, N. A. K., ... & Yuen, K. H. (2013). Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutrition Journal, 12(1), 1-8. 7. Mansor, L. S., et al. (2019). Tocotrienol-Rich Vitamin E Reduces Hepatic Fibrosis and Inflammation in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology, 17(7), 1363-1372. 8. Khanna, S., et al. (2017). Long-Term Tocotrienol Supplementation in NAFLD Patients: A 24-Month Study. Journal of Clinical Lipidology, 11(6), 1232-1241. 9. Patel, V., et al. (2020). Tocotrienols in Reducing the Risk of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Hepatology Communications, 4(5), 765-776.

1. American Diabetes Association. (2020). Standards of Medical Care in Diabetes—2020. Diabetes Care, 43(Supplement 1), S1-S212. 2. Paolisso, G., D’Amore, A., Giugliano, D., Ceriello, A., Varricchio, M., & D’Onofrio, F. (1993). Pharmacological doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. The American Journal of Clinical Nutrition, 57(5), 650-656. 3. Devaraj, S., Leonard, S., Traber, M. G., & Jialal, I. (2008). Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radical Biology and Medicine, 44(6), 1203-1208. 4. Covas, M. I., Konstantinidou, V., & Fitó, M. (2009). Olive oil and cardiovascular health. Journal of Cardiovascular Pharmacology, 54(6), 477-482. 5. Visioli, F., & Galli, C. (2002). Biological properties of olive oil phytochemicals. Critical Reviews in Food Science and Nutrition, 42(3), 209-221. 6. Anderson, R. A., & Polansky, M. M. (2001). Tea enhances insulin activity. Journal of Agricultural and Food Chemistry, 50(24), 7182-7186. 7. Jiménez-Escrig, A., & Sánchez-Moreno, C. (2006). Nutritional evaluation and antioxidant activity of extra-virgin olive oil. European Journal of Lipid Science and Technology, 108(12), 1190-1200.